Get the Stockscreener App
1.63
2.98%
-0.05
After Hours:
1.64
0.01
+0.61%
Actinium Pharmaceuticals Inc stock is traded at $1.63, with a volume of 102.75K.
It is down -2.98% in the last 24 hours and up +7.95% over the past month.
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for patients with cancers lacking effective treatment options. Its lead product candidate is Iomab-B that is in Phase III clinical studies for myeloablation and conditioning of the bone marrow prior to a bone marrow transplant for patients with relapsed or refractory acute myeloid leukemia (AML) age 55 and older. The company is also developing Actimab-A, which is in Phase II clinical trials for the treatment of patients newly diagnosed with AML over the age of 60, as well as in Phase I clinical trials in combination with CLAG-M for patients with relapsed or refractory AML; and Actimab-M that is in Phase I clinical trials for patients with refractory multiple myeloma. Actinium Pharmaceutical, Inc. was founded in 2000 and is based in New York, New York.
See More
Previous Close:
$1.68
Open:
$1.68
24h Volume:
102.75K
Relative Volume:
0.37
Market Cap:
$50.85M
Revenue:
$1.05M
Net Income/Loss:
$-48.82M
P/E Ratio:
-0.8907
EPS:
-1.83
Net Cash Flow:
$-47.49M
1W Performance:
+3.16%
1M Performance:
+7.95%
6M Performance:
+41.74%
1Y Performance:
-16.84%
1-Day Range:
$1.63
$1.68
1-Week Range:
$1.53
$1.70
52-Week Range:
$1.06
$2.41
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
Name
Actinium Pharmaceuticals Inc
Sector
Industry
Phone
646-767-3870
Address
275 Madison Avenue, 7th Floor, New York, NY
Compare ATNM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.63 | 50.23M | 1.05M | -48.82M | -47.49M | -1.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-24 | Downgrade | B. Riley Securities | Buy → Neutral |
| May-14-24 | Initiated | Stephens | Overweight |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Feb-21-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-08-22 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-25-22 | Initiated | B. Riley Securities | Buy |
| Nov-05-20 | Initiated | Alliance Global Partners | Buy |
| Dec-06-17 | Initiated | B. Riley FBR, Inc. | Buy |
| Oct-23-17 | Resumed | ROTH Capital | Buy |
| Sep-14-17 | Initiated | Maxim Group | Buy |
| Aug-25-16 | Initiated | ROTH Capital | Buy |
| Feb-29-16 | Initiated | H.C. Wainwright | Buy |
| Oct-15-15 | Initiated | FBR Capital | Outperform |
| Oct-01-14 | Initiated | MLV & Co | Buy |
| Jul-22-14 | Initiated | Canaccord Genuity | Buy |
View All
Actinium Pharmaceuticals Inc Stock (ATNM) Latest News
What to do if you’re stuck in Actinium Pharmaceuticals Inc.Trade Entry Summary & Weekly Breakout Stock Alerts - Newser
Strategies to average down on Actinium Pharmaceuticals Inc.Quarterly Performance Summary & High Yield Equity Trading Tips - Newser
How to forecast Actinium Pharmaceuticals Inc. trends using time seriesQuarterly Portfolio Report & Real-Time Volume Analysis - Newser
When is the best time to exit Actinium Pharmaceuticals Inc.Portfolio Gains Report & Real-Time Volume Spike Alerts - Newser
Real time alert setup for Actinium Pharmaceuticals Inc. performance2025 Historical Comparison & AI Forecasted Entry/Exit Points - Newser
Using RSI to spot recovery in Actinium Pharmaceuticals Inc.2025 Retail Activity & Fast Exit Strategy with Risk Control - Newser
How supply chain issues affect Actinium Pharmaceuticals Inc. stockMarket Activity Summary & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Risk vs reward if holding onto Actinium Pharmaceuticals Inc.Market Rally & Daily Stock Trend Watchlist - Newser
Combining price and volume data for Actinium Pharmaceuticals Inc.Weekly Trade Report & Safe Capital Growth Plans - Newser
Will Actinium Pharmaceuticals Inc. stock go up soonJuly 2025 Earnings & Daily Market Momentum Tracking - Newser
Has Actinium Pharmaceuticals Inc. formed a bullish divergenceIndex Update & Weekly High Momentum Picks - Newser
Using data filters to optimize entry into Actinium Pharmaceuticals Inc.2025 Pullback Review & Fast Entry High Yield Stock Tips - Newser
What the charts say about Actinium Pharmaceuticals Inc. todayJobs Report & High Win Rate Trade Alerts - Newser
Key metrics from Actinium Pharmaceuticals Inc.’s quarterly dataWeekly Profit Summary & Verified Entry Point Signals - Newser
Intraday pattern recognizer results for Actinium Pharmaceuticals Inc.Trade Exit Summary & Verified Stock Trade Ideas - Newser
Actinium Pharmaceuticals Inc. stock momentum explainedJuly 2025 Levels & Technical Buy Zone Confirmations - Newser
Applying big data sentiment scoring on Actinium Pharmaceuticals Inc.Market Volume Summary & Real-Time Volume Triggers - Newser
Analyzing net buyer seller activity in Actinium Pharmaceuticals Inc.2025 Big Picture & High Win Rate Trade Alerts - Newser
Comparing Actinium Pharmaceuticals Inc. in custom built stock radarsQuarterly Profit Report & Capital Efficiency Focused Strategies - Newser
Trend analysis for Actinium Pharmaceuticals Inc. this week2025 Short Interest & Reliable Price Action Trade Plans - Newser
Will Actinium Pharmaceuticals Inc. rebound enough to break evenEarnings Risk Summary & Weekly Watchlist for Consistent Profits - Newser
Published on: 2025-09-11 02:19:57 - Newser
How to use a screener to detect Actinium Pharmaceuticals Inc. breakoutsPortfolio Gains Report & Low Risk High Win Rate Stock Picks - Newser
Is Actinium Pharmaceuticals Inc. meeting your algorithmic filter criteria2025 Earnings Impact & Weekly High Potential Stock Alerts - Newser
Is a relief rally coming for Actinium Pharmaceuticals Inc. holdersEarnings Growth Summary & Expert Curated Trade Setup Alerts - Newser
Actinium Pharmaceuticals Inc. stock prediction for this weekJuly 2025 Summary & Proven Capital Preservation Tips - Newser
Earnings visualization tools for Actinium Pharmaceuticals Inc.2025 Institutional Moves & Breakout Confirmation Alerts - Newser
Key resistance and support levels for Actinium Pharmaceuticals Inc.2025 Market Trends & Safe Swing Trade Setups - Newser
What machine learning models say about Actinium Pharmaceuticals Inc.Chart Signals & Stepwise Swing Trade Plans - Newser
Can Actinium Pharmaceuticals Inc. outperform in the next rallyGlobal Markets & Consistent Income Trade Recommendations - Lancaster City Council
Actinium Pharmaceuticals Inc Stock (ATNM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):